Aaron Fox
Montefiore Medical Center/Albert Einstein College of Medicine · Montefiore Medical Center · Associate Professor of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aaron Fox as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:56 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07625917 · Feasibility of Internet-based HIV Prevention ResearchMontefiore Medical Center · recruiting · HIV Prevention, Injection Drug Use · principal investigator
- Ph4NCT05118204 · Randomized Trial of Buprenorphine Microdose Inductions During HospitalizationMontefiore Medical Center · terminated · Substance Use Disorders, Opioid-use Disorder, Chronic Pain · principal investigator
- Ph2NCT03150173 · Onsite Buprenorphine Treatment at Syringe Exchange ProgramsMontefiore Medical Center · completed · Opiate Addiction · principal investigator
- Ph4NCT02567968 · A Study to Determine if Caffeine Accelerates Emergence From AnesthesiaUniversity of Chicago · completed · Anesthesia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Mentorship in research on opioid use disorder treatment and HIV preventionK24DA057873 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2023 to 2026 · $184,804 awarded in 2026Grant number is on one of their registry trials
- Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV riskR01DA044878 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2017 to 2022 · $665,462 awarded in 2022Grant number is on one of their registry trials
- Reversing anesthesia with CaffeineR01GM116119 · NIGMS · UNIVERSITY OF CHICAGO · fiscal years 2015 to 2018 · $297,440 awarded in 2018Grant number is on one of their registry trials
- Buprenorphine group medical visits for drug users at risk for HIVR34DA039041 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2015 to 2017 · $55,269 awarded in 2017Same name and institution; not confirmed by an ID
- Buprenorphine Facilitated Access and Supportive Treatment in Former InmatesK23DA034541 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · fiscal years 2012 to 2016 · $182,596 awarded in 2016Same name and institution; not confirmed by an ID
- Isoflurane: Identification of Key New TargetsR01GM081809 · NIGMS · UNIVERSITY OF CHICAGO · fiscal years 2008 to 2011 · $482,770 awarded in 2011Same name and institution; not confirmed by an ID
- STUDIES OF N-TYPE CALCIUM CHANNELSR01NS026189 · NINDS · UNIVERSITY OF CHICAGO · fiscal years 1994 to 2003 · $38,281 awarded in 2003Same name and institution; not confirmed by an ID
- Nicotine Addiction: ACh Receptors and SecretionR01DA013513 · NIDA · UNIVERSITY OF CHICAGO · fiscal years 2002 · $113,438 awarded in 2002Same name and institution; not confirmed by an ID
- SYNAPTIC PHYSIOLOGYP01NS033826 · NINDS · UNIVERSITY OF CHICAGO · fiscal years 1997 to 2001 · $733,182 awarded in 2001Same name and institution; not confirmed by an ID
- CHROMAFFIN CELLS--STIMULUS SECRETION COUPLINGR01GM043560 · NIGMS · UNIVERSITY OF CHICAGO · fiscal years 1991 to 1998 · $193,877 awarded in 1998Same name and institution; not confirmed by an ID
- HIPPOCAMPAL CALCIUM CHANNELS--PHARMACOLOGY AND FUNCTIONR29NS026189 · NINDS · UNIVERSITY OF CHICAGO · fiscal years 1988 to 1992 · $109,166 awarded in 1992Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)RM1DA055437 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI JULIA H. ARNSTEN, Yuhua Bao, Vilma Gabbay, Joanna L. Starrels · fiscal years 2021 to 2025Named on NCT05118204
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:56 UTC. The ranking covers the 200 most relevant of 135 PubMed records, and a shared surname and initials can bring in a namesake. All 135 on PubMed
- Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.N Engl J Med · 19916,662 citationsRCR 253.1
- Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.N Engl J Med · 19982,686 citationsRCR 83.8
- 346 citationsRCR 12.8
- 309 citationsRCR 8.8
- Compassion training alters altruism and neural responses to suffering.Psychol Sci · 2013254 citationsRCR 10.5
- Functional but not structural subgenual prefrontal cortex abnormalities in melancholia.Mol Psychiatry · 2004252 citationsRCR 7.0
- Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.J Infect Dis · 1999169 citationsRCR 5.2
- 165 citationsRCR 6.4
- Differential impairments of selective attention due to frequency and duration of cannabis use.Biol Psychiatry · 1995164 citationsRCR 6.3
- 161 citationsRCR 6.5